Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Kanishka Chakraborty"'
Autor:
Victoria E. Palau, Kanishka Chakraborty, Daniel Wann, Janet Lightner, Keely Hilton, Marianne Brannon, William Stone, Koyamangalath Krishnan
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
Abstract Background Ceramide synthesis and metabolism is a promising target in cancer drug development. γ-tocotrienol (GT3), a member of the vitamin E family, orchestrates multiple effects that ensure the induction of apoptosis in both, wild-type an
Externí odkaz:
https://doaj.org/article/f749ecf3434342d09fbb621de6daecbe
Autor:
David G Menter, Victoria P Ramsauer, Sam Harirforoosh, Kanishka Chakraborty, Peiying Yang, Linda Hsi, Robert A Newman, Koyamangalath Krishnan
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e28813 (2011)
3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) inhibitors, commonly known as statins, may possess cancer preventive and therapeutic properties. Statins are effective suppressors of cholesterol synthesis with a well-established risk-benefit r
Externí odkaz:
https://doaj.org/article/32ec334c7acb403180dbabb4978977f7
Autor:
Purva, Sharma, Kanishka, Chakraborty
Publikováno v:
BMJ Case Reports. 15:e248116
Chylous ascites is the accumulation of lymphatic fluid in the peritoneal cavity due to disruption of lymphatic drainage caused due to obstruction or trauma. We report a man in his 60s who was previously treated for diffuse large B cell lymphoma with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d1eec675066c388751a3452ca10d37
https://doi.org/10.1136/bcr-2021-248116
https://doi.org/10.1136/bcr-2021-248116
Autor:
James J. Kim, Hemendra Mhadgut, Hakam Khazrik, Chandana Kamireddy, Oranus Mohammadi, Do Young Kim, Anna Yakubenko, Sakshi Singal, Kanishka Chakraborty, Nicole Lewis, Patrick Costello, Devapiran Jaishankar
Publikováno v:
Journal of Clinical Oncology. 40:e12506-e12506
e12506 Background: Breast cancer accounts for a million new cases annually worldwide with 40,000 deaths reported in 2020 in the United States. Treatment includes surgery, adjuvant chemotherapy, radiotherapy and endocrine therapy. Oncotype recurrence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df9c87f110fbdadc389f50441b6b3e97
https://doi.org/10.1200/jco.2022.40.16_suppl.e12506
https://doi.org/10.1200/jco.2022.40.16_suppl.e12506
Publikováno v:
Cureus
Lan is a high prevalence red blood cell antigen present in the majority of the populations that belong to the Lan (Langereis) blood group system. Anti-Lan antibody is an immunoglobulin G (IgG) antibody that is known to cause delayed hemolytic transfu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4419de438781f36003999e103ce0c1c4
https://doi.org/10.7759/cureus.10832
https://doi.org/10.7759/cureus.10832
Publikováno v:
Cureus
Survivorship care for a patient with cancer is often complex and requires a multidisciplinary approach. Cancer and its treatment can have late and long-term physical and psychosocial effects. After the acute and intense period of treatment and survei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7021d33b9e0b6ab803c283bec83233f
https://doi.org/10.7759/cureus.10210
https://doi.org/10.7759/cureus.10210
Publikováno v:
BMJ Case Reports. 14:e243764
Immune checkpoint inhibitors can cause immune side effects, with myasthenia gravis (MG) being relatively rare. With this review, we present 66-year-old man with melanoma treated with pembrolizumab who developed MG. With immuno-oncology (IO) single ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de8a1567d2993034239c97f5cd6f166a
https://doi.org/10.1136/bcr-2021-243764
https://doi.org/10.1136/bcr-2021-243764
Publikováno v:
BMJ Case Rep
Non-producing variant of plasma cell disorders with circulating plasma cells is an aggressive variant of plasma cell dyscrasias with relatively poor outcomes. A 75-year-old man was admitted due to anaemia (90 g/L) and thrombocytopenia (9×109/L). Com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f548a33c76d4f2b0c536794079d14b40
https://europepmc.org/articles/PMC6887463/
https://europepmc.org/articles/PMC6887463/
Publikováno v:
Cureus
Breast cancer is the most common cancer in a woman with a five-year survival of patients with metastatic disease is estimated at 23%. Ado-trastuzumab emtansine (T-DM1) is a HER2-antibody drug conjugate currently approved for the treatment of HER2-pos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fba3328b098244378c1faa80d94a8db
https://doi.org/10.7759/cureus.6036
https://doi.org/10.7759/cureus.6036
Autor:
Kanishka Chakraborty, Sukesh Manthri
Publikováno v:
BMJ Case Rep
Molecular targeted agents have emerged as an important part of systemic therapy for many cancer types. Cetuximab is a recombinant human/mouse chimeric monoclonal antibody which competitively inhibits the binding of epidermal growth factor (EGF) and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39b2583515f8ee7b20193923d21b31c7
https://europepmc.org/articles/PMC6720710/
https://europepmc.org/articles/PMC6720710/